Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva to buy Merck KGaA's women's health unit
Reuters
Thursday, October 28, 2010 - 11:43am
tags:
Women's Health, Teva Pharmaceuticals, M&A, Merck KGaA
Pfizer's lung cancer drug crizotinib shows early promise
Fierce Biotech
Thursday, October 28, 2010 - 11:40am
tags:
crizotinib, Pfizer, lung cancer
Celgene 3Q profit rises on cancer drug sales
Yahoo/AP
Thursday, October 28, 2010 - 11:38am
tags:
Celgene, earnings
Brand-Name Drugmakers Not Liable For Generics
Pharmalot
Thursday, October 28, 2010 - 11:02am
tags:
generics, Wyeth, Pfizer, Reglan, Schwarz
The 3 Words Every Biotech Investor Wants to Hear
Motley Fool
Thursday, October 28, 2010 - 11:00am
tags:
biotech, Acorda Therapeutics, Elan, JNJ, Biogen Idec
United Therapeutics earnings triple to $39.7M
Bizjournals.com
Thursday, October 28, 2010 - 9:48am
tags:
earnings, United Therapeutics
Novartis Wins Challenge Against J&J Over Its French Contact Lens Patent
Bloomberg
Thursday, October 28, 2010 - 9:47am
tags:
France, JNJ, Novartis, patents, contact lens
Keryx Biopharm: A Promising Long Term Pick
Seeking Alpha
Thursday, October 28, 2010 - 8:53am
tags:
Keryx, Zerenex
NJ's Savient plans to handle launch of new gout drug on its own
Newark Star-Ledger, NJ
Thursday, October 28, 2010 - 8:11am
tags:
Savient, gout, Krystexxa
Sanofi’s Viehbacher Rules Out $80-a-Share Offer for Genzyme
Bloomberg
Thursday, October 28, 2010 - 8:06am
tags:
Genzyme, Sanofi, Chris Viehbacher, M&A
AstraZeneca Q3 profit down 27 pct amid legal costs
Yahoo/AP
Thursday, October 28, 2010 - 8:05am
tags:
earnings, AstraZeneca
Sanofi-Aventis Earnings Jump 13%
TheStreet.com
Thursday, October 28, 2010 - 8:03am
tags:
earnings, Sanofi
Biotech ETFs Up As Biogen, Illumina, Amylin Soar
Barron's
Wednesday, October 27, 2010 - 9:08pm
tags:
Biogen Idec, Amylin, Illumina, ETFs
Could Overtime Lawsuits Spread to Pfizer? Two Claims Suggest So
BNET Pharma
Wednesday, October 27, 2010 - 5:55pm
tags:
overtime lawsuits, Pfizer, King, Alpharma
Earnings Preview: Celgene
Seeking Alpha
Wednesday, October 27, 2010 - 4:02pm
tags:
earnings, Celgene
Avanir: The Short and Long of AVP-923
TheStreet.com
Wednesday, October 27, 2010 - 4:01pm
tags:
Avanir, AVP-923
A Disappointing Diabetes-Drug Development
WSJ Online
Wednesday, October 27, 2010 - 4:00pm
tags:
diabetes, Phenomix, Forest Labs
Bristol-Myers: FDA finds problems at Puerto Rico plant; could delay approval of new drugs
Yahoo/AP
Wednesday, October 27, 2010 - 12:25pm
tags:
FDA, Bristol-Myers Squibb, drug manufacturing
P&G says net income fell 7 percent in 1Q
Yahoo/AP
Wednesday, October 27, 2010 - 12:22pm
tags:
earnings, P&G
The Single Biggest Reason we need Big Pharma Drug Discovery
Pharmareform
Wednesday, October 27, 2010 - 12:08pm
tags:
innovation, R&D, drug development, Big Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.